Stearns A T, Hole D, George W D, Kingsmore D B
Department of General and Vascular Surgery, Gartnavel General Hospital, Glasgow, UK.
Br J Surg. 2007 Aug;94(8):957-65. doi: 10.1002/bjs.5667.
Traditional survival curves cannot easily be used to predict outcome for an individual patient on a year-to-year basis. This difficulty is partly overcome by yearly mortality analysis. This method was employed to analyse long-term follow-up of three cancers: colorectal, ovarian and breast cancer.
The study used prospectively collected cancer registry data from geographically defined regions in Scotland. Cohort sizes were 7196 patients with breast cancer, 3200 with colorectal cancer and 1866 with ovarian cancer. Follow-up extended to 23 years.
Two distinct patterns of mortality emerged. Mortality rates for ovarian and colorectal cancer were initially high (41 and 21 per cent) but decreased rapidly; by 10 years patients had either died or were cured. The influence of stage diminished with follow-up. Breast cancer mortality was lower than that of colorectal or ovarian cancer, but remained raised in comparison to the general population throughout follow-up. The influence of breast cancer size reduced with follow-up, whereas that of nodal status persisted.
Patients with breast cancer live at increased risk of death to the end of follow-up, supporting the concept of dormancy in breast cancer biology. This was not observed with colorectal or ovarian cancer.
传统的生存曲线难以逐年预测个体患者的预后。年度死亡率分析在一定程度上克服了这一困难。本方法用于分析三种癌症(结直肠癌、卵巢癌和乳腺癌)的长期随访情况。
本研究使用了从苏格兰地理界定区域前瞻性收集的癌症登记数据。队列规模为7196例乳腺癌患者、3200例结直肠癌患者和1866例卵巢癌患者。随访期延长至23年。
出现了两种不同的死亡率模式。卵巢癌和结直肠癌的死亡率最初较高(分别为41%和21%),但迅速下降;到10年时,患者要么死亡,要么治愈。分期的影响随随访时间减弱。乳腺癌死亡率低于结直肠癌或卵巢癌,但在整个随访期间与普通人群相比仍居高不下。乳腺癌大小的影响随随访时间减小,而淋巴结状态的影响持续存在。
乳腺癌患者在随访结束时死亡风险增加,支持乳腺癌生物学中休眠的概念。结直肠癌或卵巢癌未观察到这种情况。